Share This Story!

Let friends in your social network know what you are reading about

FDA Delays Breast Cancer Drug Avastin Decision

FDA Delays Breast Cancer Drug Avastin Decision

Drugmaker Roche said Friday that U.S. health regulators will take more time to review its drug Avastin for breast cancer, a use that has generated vigorous debate among cancer specialists and patients.

Posted!

A link has been posted to your Facebook feed.

Join the Conversation

To find out more about Facebook commenting please read the Conversation Guidelines and FAQs

FDA Delays Breast Cancer Drug Avastin Decision

Drugmaker Roche said Friday that U.S. health regulators will take more time to review its drug Avastin for breast cancer, a use that has generated vigorous debate among cancer specialists and patients.